These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 7483181

  • 1. Asymptomatic cardiac ischemia pilot (ACIP).
    Conti CR, Bourassa MG, Chaitman BR, Geller NL, Knatterud GL, Pepine CJ, Pratt C, Sopko G.
    Trans Am Clin Climatol Assoc; 1995; 106():77-83; discussion 83-4. PubMed ID: 7483181
    [Abstract] [Full Text] [Related]

  • 2. [Economic evaluation of different treatment strategies in patients with stable angina pectoris or asymptomatic myocardial ischemia on basis of results from the Asymptomatic-Cardiac-Ischemia Pilot study (ACIP)].
    Szucs TD, Schwenkglenks M, Rutishauser W.
    Med Klin (Munich); 2000 Jan 15; 95(1):1-13. PubMed ID: 10668338
    [Abstract] [Full Text] [Related]

  • 3. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India.
    J Assoc Physicians India; 2006 Jun 15; 54():469-80. PubMed ID: 16909697
    [Abstract] [Full Text] [Related]

  • 4. Asymptomatic Cardiac Ischemia Pilot (ACIP) study: outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. The ACIP Investigators.
    Rogers WJ, Bourassa MG, Andrews TC, Bertolet BD, Blumenthal RS, Chaitman BR, Forman SA, Geller NL, Goldberg AD, Habib GB.
    J Am Coll Cardiol; 1995 Sep 15; 26(3):594-605. PubMed ID: 7642848
    [Abstract] [Full Text] [Related]

  • 5. Asymptomatic Cardiac Ischemia Pilot (ACIP) study: effects of coronary angioplasty and coronary artery bypass graft surgery on recurrent angina and ischemia. The ACIP investigators.
    Bourassa MG, Pepine CJ, Forman SA, Rogers WJ, Dyrda I, Stone PH, Chaitman BR, Sharaf B, Mahmarian J, Davies RF.
    J Am Coll Cardiol; 1995 Sep 15; 26(3):606-14. PubMed ID: 7642849
    [Abstract] [Full Text] [Related]

  • 6. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W, Lopes NH, Gersh BJ, Soares P, Machado LA, Jatene FB, Oliveira SA, Ramires JA.
    Circulation; 2007 Mar 06; 115(9):1082-9. PubMed ID: 17339566
    [Abstract] [Full Text] [Related]

  • 7. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.
    Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, Weintraub WS, O'Rourke RA, Dada M, Spertus JA, Chaitman BR, Friedman J, Slomka P, Heller GV, Germano G, Gosselin G, Berger P, Kostuk WJ, Schwartz RG, Knudtson M, Veledar E, Bates ER, McCallister B, Teo KK, Boden WE, COURAGE Investigators.
    Circulation; 2008 Mar 11; 117(10):1283-91. PubMed ID: 18268144
    [Abstract] [Full Text] [Related]

  • 8. Silent ischemia: clinical relevance.
    Conti CR, Bavry AA, Petersen JW.
    J Am Coll Cardiol; 2012 Jan 31; 59(5):435-41. PubMed ID: 22281245
    [Abstract] [Full Text] [Related]

  • 9. [Physiopathologic introduction to anesthesia and resuscitation of the vascular patient].
    Coriat P.
    J Mal Vasc; 1998 Feb 31; 23(1):35-40. PubMed ID: 9551351
    [Abstract] [Full Text] [Related]

  • 10. PCI versus CABG versus medical therapy in 2006.
    Morrison D.
    Minerva Cardioangiol; 2006 Oct 31; 54(5):643-72. PubMed ID: 17019400
    [Abstract] [Full Text] [Related]

  • 11. Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study.
    Stone PH, Lloyd-Jones DM, Kinlay S, Frei B, Carlson W, Rubenstein J, Andrews TC, Johnstone M, Sopko G, Cole H, Orav J, Selwyn AP, Creager MA, Vascular Basis Study Group.
    Circulation; 2005 Apr 12; 111(14):1747-55. PubMed ID: 15809368
    [Abstract] [Full Text] [Related]

  • 12. Ten-year mortality rate in relation to observations at a bicycle exercise test in patients with a suspected or confirmed ischemic event but no or only minor myocardial damage: influence of subsequent revascularization.
    Karlson BW, Sjölin M, Lindqvist J, Caidahl K, Herlitz J.
    Am Heart J; 2001 Jun 12; 141(6):977-84. PubMed ID: 11376313
    [Abstract] [Full Text] [Related]

  • 13. [Silent myocardial ischemia and nitrates].
    Palma Gámiz JL.
    Ann Cardiol Angeiol (Paris); 1997 Jun 12; 46(7):431-40. PubMed ID: 9452778
    [Abstract] [Full Text] [Related]

  • 14. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization.
    Davies RF, Goldberg AD, Forman S, Pepine CJ, Knatterud GL, Geller N, Sopko G, Pratt C, Deanfield J, Conti CR.
    Circulation; 1997 Apr 15; 95(8):2037-43. PubMed ID: 9133513
    [Abstract] [Full Text] [Related]

  • 15. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.
    Teo KK, Sedlis SP, Boden WE, O'Rourke RA, Maron DJ, Hartigan PM, Dada M, Gupta V, Spertus JA, Kostuk WJ, Berman DS, Shaw LJ, Chaitman BR, Mancini GB, Weintraub WS, COURAGE Trial Investigators.
    J Am Coll Cardiol; 2009 Sep 29; 54(14):1303-8. PubMed ID: 19778673
    [Abstract] [Full Text] [Related]

  • 16. Asymptomatic Cardiac Ischemia Pilot (ACIP) study: impact of anti-ischemia therapy on 12-week rest electrocardiogram and exercise test outcomes. The ACIP Investigators.
    Chaitman BR, Stone PH, Knatterud GL, Forman SA, Sopko G, Bourassa MG, Pratt C, Rogers WJ, Pepine CJ, Conti CR.
    J Am Coll Cardiol; 1995 Sep 29; 26(3):585-93. PubMed ID: 7642847
    [Abstract] [Full Text] [Related]

  • 17. Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot study.
    Erne P, Schoenenberger AW, Zuber M, Burckhardt D, Kiowski W, Dubach P, Resink T, Pfisterer M.
    Eur Heart J; 2007 Sep 29; 28(17):2110-7. PubMed ID: 17644512
    [Abstract] [Full Text] [Related]

  • 18. [Asymptomatic ischemia--an important part of the spectrum of coronary disease].
    Rutishauser W, Lerch R.
    Praxis (Bern 1994); 1995 Oct 17; 84(42):1181-5. PubMed ID: 7481331
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
    Fox KA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ, Yusuf S, Clopidogrel in Unstable angina to prevent Recurrent ischemic Events Trial.
    Circulation; 2004 Sep 07; 110(10):1202-8. PubMed ID: 15313956
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.